(3.235.108.188) 您好!臺灣時間:2021/03/07 21:24
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:張愉珮
研究生(外文):Yu-Pei Chang
論文名稱:降解克雷伯氏肺炎菌K2(A4528)莢膜多醣之嗜菌體酵素的純化及其生化特性的探討
論文名稱(外文):Purification and biochemical characterization of a bacteriophage hydrolase to degrade capsular polysaccharideof PLA Klebsiella pneumoniae K2 (A4528)
指導教授:吳世雄吳世雄引用關係
指導教授(外文):Shih-Hsiung Wu
口試委員:梁博煌花國鋒徐駿森
口試委員(外文):Po-Huang LiangKuo-Feng HuaChun-Hua Hsu
口試日期:2014-07-10
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:化學研究所
學門:自然科學學門
學類:化學學類
論文種類:學術論文
論文出版年:2014
畢業學年度:102
語文別:英文
論文頁數:67
中文關鍵詞:克雷伯氏肺炎菌化膿性肝膿瘍醣複合疫苗莢膜血清型K2莢膜多醣K2水解&;#37238;
外文關鍵詞:Klebsiella pneumoniaepyogenic liver abscessglycoconjugate vaccinesK2 serotypecapsular polysaccharideK2 hydrolase
相關次數:
  • 被引用被引用:0
  • 點閱點閱:112
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
過去二十幾年來,在亞洲地區特別在台灣,導致化膿性肝膿瘍的克雷伯氏肺炎菌是社區型及院內感染常見的病原體,有相當高的發病率以及致死率。臨床研究顯示,莢膜血清型K1及K2就約佔77.6 %。隨著會分泌廣效性乙內醯胺&;#37238;的克雷伯氏肺炎菌比率不斷增加,多重抗藥性的問題愈趨嚴重,使得治療更加地棘手,由細菌莢膜多醣製成的醣複合疫苗可能是一個解決現在困境的策略。然而多醣因為分子量太大,不易架接至載體蛋白成為有效抗原,所以我們利用嗜菌體的尾巴蛋白將克雷伯氏肺炎菌A4528(莢膜血清型K2)的莢膜多醣水解成寡糖,以提升架接產率,成為有效抗原。
在此論文中,主要探討K2水解&;#37238;的生物物理特性及其與受質K2莢膜多醣的相互作用。藉由嗜菌體篩選,兩個K2莢膜多醣水解&;#37238;被選殖出來,其兩者序列的相似度只有25.4 %,並探討兩者間特性的比較: 首先進行圓二色性光譜以及分析超速離心來偵測其二級結構和蛋白質自然狀態,此兩個水解&;#37238;的二級結構皆為β折疊以及以三聚物形式存在;另外也使用X光晶體繞射學來研究晶體結構,目前收到一組K2-1水解&;#37238;的結晶資訊,其解析度為3.58 A。而水解&;#37238;切割莢膜多醣的活性可藉由3,5-二硝基水楊酸來定量水解後新增還原端的含量,K2-1的最佳緩衝液為20 mM NaOAc/MES/HEPES、100 mM NaCl,pH值6,在溫度為37 ℃下有最佳的酵素活性;至於K2-2則是在緩衝液為20 mM sodium citrate、100 mM NaCl,pH值5,在溫度為50 ℃下有最大的活性。並利用質譜儀來鑑定經由水解&;#37238;反應後多醣片段的型式,從質譜圖推斷無論是K2-1或K2-2水解片段, 主要以單聚體(四寡醣)為主,亦有二聚體(八寡醣)。最後,利用核磁共振來解析K2-2水解&;#37238;的切點,從各類不同圖譜推斷其切點位於葡萄糖和甘露糖中間的1,4-β-1,4連結。

Klebsiella pneumoniae is a common cause of community-acquired and nosocomail infections that causes pyogenic liver abscess (PLA) in Asian over two decades, especial in Taiwan area, and leads to significant morbidity and mortality. The clinic investigation showed that K. pneumoniae serotypes K1/K2 are predominant among capsular serotypes of virulent PLA strains, around 77.6%. Besides, infection caused by extended-spectrum β-lactamase (ESBL)-producing pathogens, particularly K. pneumoniae, are increasing. Because of resistance to numerous antimicrobial agents, treatment turns into a critical medical issue. Hence, glycoconjugate vaccines which source from capsular polysaccharide of bacteria would offer one kind of solution to this bacterial infection. Since polysaccharide is too large to be conjugated to a carrier protein, hard to become an effective antigen, the depolymerization of capsular polysaccharide would result in the increasing yield of the coupling. Thus, we utilized a tail fiber enzyme from bacteriophage to cleave the capsular polysaccharide of K. pneumoniae A4528 (serotype K2) into smaller sugar fragments, in order to increase the effective conjugation during antigen preparation.
In this study, two low-identical K2 hydrolases (25.4 %) were cloned from different K2-bacteriophages. Based on biophysical instrumentation, including CD and AUC, the secondary structures and native state of the proteins were determined. The conformation of K2 hydrolases are primarily in β-sheet and exist as trimers. Besides, X-ray crystallography was applied to dissect the atomic structure of K2 hydrolase. To date, the crystallographic data of K2-1 hydrolase was collected which resolution was 3.58 A. Otherwise, in the aspect of interaction between enzyme and substrate, the enzymatic activity could be measured by 3,5-dinitrosalicylic acid which enable to quantify the forming of new reducing end of sugars once hydrolase digested CPS. With a series of screening, the optimal conditions of the two hydrolases were determined. K2-1 and K2-2 have the maximum activities in optimal conditions: 20 mM NaOAc/MES/HEPES buffer with 100 mM NaCl at pH 6 and 37 ℃, and 20 mM sodium citrate buffer with 100 mM NaCl at pH 5 and 50 ℃, respectively. To understand the fragments of hydrolase-digested CPS, mass spectrometry was applied. From the results of MALDI-TOF spectra, the major products of hydrolase-digested CPS are one-repeat unit (monomer; tetrasaccharides) and two-repeated units (dimer; octasaccharides) as minor. Additionally, the cutting site of hydrolase-digested CPS was identified by NMR analysis. After resolving NMR spectra, we found that the cutting site of K2-2-digested CPS is located in the β-1,4 linkage between glucose and mannose.

謝誌 I
摘要 II
Abstract III
List of Figures VII
List of Tables IX
Abbreviation Table X
1 Introduction 1
1-1 Klebsiella pneumoniae 1
1-2 Pyogenic liver abscess (PLA) 3
1-3 Extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae 3
1-4 Capsular polysaccharide (CPS) 4
1-5 Glycoside hydrolase 6
1-6 Glycoconjugate vaccine 8
1-7 Purpose of this research 9
2 Materials and Methods 11
2-1 Protein expression and purification 11
2-2 Phylogenetic analysis and sequence alignment of K2 hydrolase 12
2-3 Circular dichroism (CD) spectra 12
2-4 Analytical ultracentrifugation (AUC) analysis 13
2-5 X-ray crystallography 14
2-6 Capsular polysaccharide purification 15
2-7 Quantification of reducing ends with 3,5-dinitrosalicylic acid (DNSA) assay 15
2-8 MALDI-TOF spectra 17
2-9 MS/MS spectra 18
2-10 NMR spectroscopy 18
3 Results 20
3-1 The sequence relationship of two K2 hydrolases of PLA K. p and other related hydrolases 20
3-1-1 Phylogenetic analysis of K2 hydrolases 20
3-1-2 Protein sequence alignment of K2-1 and K2-2 22
3-2 Biophysical characterization of K2-1 and K2-2 23
3-2-2 Analytical ultracentrifugation analysis 24
3-3 X-ray crystallography for K2 hydrolases 27
3-4 Biochemical assay for K2 hydrolase 29
3-4-1 Optimal pH screening 29
3-4-3 Optimal buffer screening 33
3-4-4 Comparison of the activity between K2-1 and K2-2 35
3-5 MS and MS/MS analysis of hydrolase-digested capsular polysaccharide 36
3-6 NMR analysis of K2-2-digested CPS 39
4 Conclusion and Discussion 48
5 References 56


1.Bagley, S. T. (1985) Habitat association of Klebsiella species, Infection control : IC 6, 52-58.
2.Podschun, R., and Ullmann, U. (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors, Clinical microbiology reviews 11, 589-603.
3.Bagley, S. T., Seidler, R. J., Talbot, H. W., Jr., and Morrow, J. E. (1978) Isolation of Klebsielleae from within living wood, Applied and environmental microbiology 36, 178-185.
4.Brown, C., and Seidler, R. J. (1973) Potential pathogens in the environment: Klebsiella pneumoniae, a taxonomic and ecological enigma, Applied microbiology 25, 900-904.
5.Edberg, S. C., Piscitelli, V., and Cartter, M. (1986) Phenotypic characteristics of coliform and noncoliform bacteria from a public water supply compared with regional and national clinical species, Applied and environmental microbiology 52, 474-478.
6.Zaidi, A. K., Huskins, W. C., Thaver, D., Bhutta, Z. A., Abbas, Z., and Goldmann, D. A. (2005) Hospital-acquired neonatal infections in developing countries, Lancet 365, 1175-1188.
7.Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., and Edmond, M. B. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 39, 309-317.
8.Ho, M., McDonald, L. C., Lauderdale, T. L., Yeh, L. L., Chen, P. C., and Shiau, Y. R. (1999) Surveillance of antibiotic resistance in Taiwan, 1998, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 32, 239-249.
9.Ko, W. C., Paterson, D. L., Sagnimeni, A. J., Hansen, D. S., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., McCormack, J. G., and Yu, V. L. (2002) Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns, Emerging infectious diseases 8, 160-166.
10.Tsai, F. C., Huang, Y. T., Chang, L. Y., and Wang, J. T. (2008) Pyogenic liver abscess as endemic disease, Taiwan, Emerging infectious diseases 14, 1592-1600.
11.Fung, C. P., Hu, B. S., Chang, F. Y., Lee, S. C., Kuo, B. I., Ho, M., Siu, L. K., and Liu, C. Y. (2000) A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy, The Journal of infectious diseases 181, 2075-2079.
12.Wang, J. H., Liu, Y. C., Lee, S. S., Yen, M. Y., Chen, Y. S., Wann, S. R., and Lin, H. H. (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 26, 1434-1438.
13.Yeh, K. M., Kurup, A., Siu, L. K., Koh, Y. L., Fung, C. P., Lin, J. C., Chen, T. L., Chang, F. Y., and Koh, T. H. (2007) Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan, Journal of clinical microbiology 45, 466-471.
14.Lee, K. H., Hui, K. P., Tan, W. C., and Lim, T. K. (1994) Klebsiella bacteraemia: a report of 101 cases from National University Hospital, Singapore, The Journal of hospital infection 27, 299-305.
15.Chuang, Y. P., Fang, C. T., Lai, S. Y., Chang, S. C., and Wang, J. T. (2006) Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess, The Journal of infectious diseases 193, 645-654.
16.Fang, F. C., Sandler, N., and Libby, S. J. (2005) Liver abscess caused by magA+ Klebsiella pneumoniae in North America, Journal of clinical microbiology 43, 991-992.
17.Rahimian, J., Wilson, T., Oram, V., and Holzman, R. S. (2004) Pyogenic liver abscess: recent trends in etiology and mortality, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 39, 1654-1659.
18.Nadasy, K. A., Domiati-Saad, R., and Tribble, M. A. (2007) Invasive Klebsiella pneumoniae syndrome in North America, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45, e25-28.
19.Montgomerie, J. Z. (1979) Epidemiology of Klebsiella and hospital-associated infections, Reviews of infectious diseases 1, 736-753.
20.Chiu, C. H., Su, L. H., Wu, T. L., and Hung, I. J. (2001) Liver abscess caused by Klebsiella pneumoniae in siblings, Journal of clinical microbiology 39, 2351-2353.
21.Lin, Y. T., Siu, L. K., Lin, J. C., Chen, T. L., Tseng, C. P., Yeh, K. M., Chang, F. Y., and Fung, C. P. (2012) Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries, BMC microbiology 12, 13.
22.Rubin, R. H., Swartz, M. N., and Malt, R. (1974) Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects, The American journal of medicine 57, 601-610.
23.Barnes, P. F., De Cock, K. M., Reynolds, T. N., and Ralls, P. W. (1987) A comparison of amebic and pyogenic abscess of the liver, Medicine 66, 472-483.
24.Gyorffy, E. J., Frey, C. F., Silva, J., Jr., and McGahan, J. (1987) Pyogenic liver abscess. Diagnostic and therapeutic strategies, Annals of surgery 206, 699-705.
25.Sabbaj, J. (1984) Anaerobes in liver abscess, Reviews of infectious diseases 6 Suppl 1, S152-156.
26.Itokazu, G. S., Quinn, J. P., Bell-Dixon, C., Kahan, F. M., and Weinstein, R. A. (1996) Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 23, 779-784.
27.Burwen, D. R., Banerjee, S. N., and Gaynes, R. P. (1994) Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System, The Journal of infectious diseases 170, 1622-1625.
28.Gniadkowski, M. (2001) Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 7, 597-608.
29.Nijssen, S., Florijn, A., Bonten, M. J., Schmitz, F. J., Verhoef, J., and Fluit, A. C. (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates, International journal of antimicrobial agents 24, 585-591.
30.Coque, T. M., Baquero, F., and Canton, R. (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe, Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 13.
31.Miriagou, V., Papagiannitsis, C. C., Kotsakis, S. D., Loli, A., Tzelepi, E., Legakis, N. J., and Tzouvelekis, L. S. (2010) Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-beta-lactamase gene in Klebsiella pneumoniae, Antimicrobial agents and chemotherapy 54, 4497-4502.
32.Nathisuwan, S., Burgess, D. S., and Lewis, J. S., 2nd. (2001) Extended-spectrum beta-lactamases: epidemiology, detection, and treatment, Pharmacotherapy 21, 920-928.
33.Sirot, D., De Champs, C., Chanal, C., Labia, R., Darfeuille-Michaud, A., Perroux, R., and Sirot, J. (1991) Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli, Antimicrobial agents and chemotherapy 35, 1576-1581.
34.Jacoby, G. A., and Sutton, L. (1991) Properties of plasmids responsible for production of extended-spectrum beta-lactamases, Antimicrobial agents and chemotherapy 35, 164-169.
35.Hibbert-Rogers, L. C., Heritage, J., Gascoyne-Binzi, D. M., Hawkey, P. M., Todd, N., Lewis, I. J., and Bailey, C. (1995) Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward, The Journal of antimicrobial chemotherapy 36, 65-82.
36.Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., and Calfee, D. P. (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies, Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 29, 1099-1106.
37.Neuner, E. A., Yeh, J. Y., Hall, G. S., Sekeres, J., Endimiani, A., Bonomo, R. A., Shrestha, N. K., Fraser, T. G., and van Duin, D. (2011) Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections, Diagnostic microbiology and infectious disease 69, 357-362.
38.Kaiser, R. M., Castanheira, M., Jones, R. N., Tenover, F., and Lynfield, R. (2013) Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program, Diagnostic microbiology and infectious disease 76, 356-360.
39.Chang, F.-Y. (2012) Annual report from Taiwan Nosocomial Infection Surveillance Systems.
40.Klipstein, F. A., Horowitz, I. R., Engert, R. F., and Schnenk, E. A. (1975) Effect of Klebsiella pneumoniae enterotoxin on intestinal transport in the rat, The Journal of clinical investigation 56, 799-807.
41.Klipstein, F. A., Engert, R. F., and Houghten, R. A. (1983) Immunological properties of purified Klebsiella pneumoniae heat-stable enterotoxin, Infection and immunity 42, 838-841.
42.Koo, F. C. W., and Stein, M. D. (1986) Detection of an extracellular toxin produced by burn isolates of Klebsiella pneumoniae, Current Microbiology 13, 23-27.
43.Tomas, J. M., Camprubi, S., Merino, S., Davey, M. R., and Williams, P. (1991) Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens, Infection and immunity 59, 2006-2011.
44.Podschun, R., Penner, I., and Ullmann, U. (1992) Interaction of Klebsiella capsule type 7 with human polymorphonuclear leucocytes, Microbial pathogenesis 13, 371-379.
45.Fung, C. P., Chang, F. Y., Lin, J. C., Ho, D. M., Chen, C. T., Chen, J. H., Yeh, K. M., Chen, T. L., Lin, Y. T., and Siu, L. K. (2011) Immune response and pathophysiological features of Klebsiella pneumoniae liver abscesses in an animal model, Laboratory investigation; a journal of technical methods and pathology 91, 1029-1039.
46.Blanchette, E. A., and Rubin, S. J. (1980) Seroepidemiology of clinical isolates of Klebsiella in Connecticut, Journal of clinical microbiology 11, 474-478.
47.Pan, Y. J., Fang, H. C., Yang, H. C., Lin, T. L., Hsieh, P. F., Tsai, F. C., Keynan, Y., and Wang, J. T. (2008) Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype, Journal of clinical microbiology 46, 2231-2240.
48.Chung, D. R., Lee, S. S., Lee, H. R., Kim, H. B., Choi, H. J., Eom, J. S., Kim, J. S., Choi, Y. H., Lee, J. S., Chung, M. H., Kim, Y. S., Lee, H., Lee, M. S., and Park, C. K. (2007) Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea, The Journal of infection 54, 578-583.
49.Fung, C. P., Chang, F. Y., Lee, S. C., Hu, B. S., Kuo, B. I., Liu, C. Y., Ho, M., and Siu, L. K. (2002) A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?, Gut 50, 420-424.
50.Fung, C. P., and Siu, L. K. (2007) Virulence of Klebsiella pneumoniae serotype K2 should not be underestimated in K. pneumoniae liver abscess, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 45, 1530-1531; author reply 1532-1533.
51.Cryz, S. J., Jr., Mortimer, P. M., Mansfield, V., and Germanier, R. (1986) Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development, Journal of clinical microbiology 23, 687-690.
52.Jenney, A. W., Clements, A., Farn, J. L., Wijburg, O. L., McGlinchey, A., Spelman, D. W., Pitt, T. L., Kaufmann, M. E., Liolios, L., Moloney, M. B., Wesselingh, S. L., and Strugnell, R. A. (2006) Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development, Journal of clinical microbiology 44, 102-107.
53.Legakis, N. J., Tzouvelekis, L. S., Hatzoudis, G., Tzelepi, E., Gourkou, A., Pitt, T. L., and Vatopoulos, A. C. (1995) Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase, The Journal of hospital infection 31, 177-187.
54.Smith, S. M., Digori, J. T., and Eng, R. H. (1982) Epidemiology of Klebsiella antibiotic resistance and serotypes, Journal of clinical microbiology 16, 868-873.
55.Mizuta, K., Ohta, M., Mori, M., Hasegawa, T., Nakashima, I., and Kato, N. (1983) Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types, Infection and immunity 40, 56-61.
56.Yu, W. L., Ko, W. C., Cheng, K. C., Lee, C. C., Lai, C. C., and Chuang, Y. C. (2008) Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes, Diagnostic microbiology and infectious disease 62, 1-6.
57.Corsaro, M. M., De Castro, C., Naldi, T., Parrilli, M., Tomas, J. M., and Regue, M. (2005) 1H and 13C NMR characterization and secondary structure of the K2 polysaccharide of Klebsiella pneumoniae strain 52145, Carbohydrate research 340, 2212-2217.
58.Wilson, D. B. (2009) Cellulases and biofuels, Current opinion in biotechnology 20, 295-299.
59.Abbott, D. W., Macauley, M. S., Vocadlo, D. J., and Boraston, A. B. (2009) Streptococcus pneumoniae endohexosaminidase D, structural and mechanistic insight into substrate-assisted catalysis in family 85 glycoside hydrolases, The Journal of biological chemistry 284, 11676-11689.
60.Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., and Vocadlo, D. J. (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo, Nature chemical biology 4, 483-490.
61.Bardgett, R. D., Freeman, C., and Ostle, N. J. (2008) Microbial contributions to climate change through carbon cycle feedbacks, The ISME journal 2, 805-814.
62.Davies, G., and Henrissat, B. (1995) Structures and mechanisms of glycosyl hydrolases, Structure 3, 853-859.
63.Anderson, P. (1983) Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197, Infection and immunity 39, 233-238.
64.Taylor, D. N., Trofa, A. C., Sadoff, J., Chu, C., Bryla, D., Shiloach, J., Cohen, D., Ashkenazi, S., Lerman, Y., Egan, W., and et al. (1993) Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids, Infection and immunity 61, 3678-3687.
65.Stein, K. E. (1992) Thymus-independent and thymus-dependent responses to polysaccharide antigens, The Journal of infectious diseases 165 Suppl 1, S49-52.
66.Pollard, A. J., Perrett, K. P., and Beverley, P. C. (2009) Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines, Nature reviews. Immunology 9, 213-220.
67.Avci, F. Y., Li, X., Tsuji, M., and Kasper, D. L. (2011) A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design, Nature medicine 17, 1602-1609.
68.Pace, D. (2013) Glycoconjugate vaccines, Expert opinion on biological therapy 13, 11-33.
69.Ahmad, T. A., El-Sayed, L. H., Haroun, M., Hussein, A. A., and El Ashry el, S. H. (2012) Development of immunization trials against Klebsiella pneumoniae, Vaccine 30, 2411-2420.
70.Campbell, W. N., Hendrix, E., Cryz, S., Jr., and Cross, A. S. (1996) Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 23, 179-181.
71.Chhibber, S., and Bajaj, J. (1995) Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia, Vaccine 13, 179-184.
72.Edelman, R., Taylor, D. N., Wasserman, S. S., McClain, J. B., Cross, A. S., Sadoff, J. C., Que, J. U., and Cryz, S. J. (1994) Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously, Vaccine 12, 1288-1294.
73.Yadav, V., Sharma, S., Harjai, K., Mohan, H., and Chhibber, S. (2005) Lipopolysaccharide-mediated protection against Klebsiella pneumoniae-induced lobar pneumonia: intranasal vs. intramuscular route of immunization, Folia microbiologica 50, 83-86.
74.Cryz, S. J., Jr., Furer, E., and Germanier, R. (1985) Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans, The Journal of infectious diseases 151, 665-671.
75.Cryz, S. J., Jr. (1990) Klebsiella polysaccharide vaccines, Advances in biotechnological processes 13, 87-103.
76.Cryz, S. J., Jr., Mortimer, P., Cross, A. S., Furer, E., and Germanier, R. (1986) Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans, Vaccine 4, 15-20.
77.Yang, F. L., Yang, Y. L., Liao, P. C., Chou, J. C., Tsai, K. C., Yang, A. S., Sheu, F., Lin, T. L., Hsieh, P. F., Wang, J. T., Hua, K. F., and Wu, S. H. (2011) Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4, The Journal of biological chemistry 286, 21041-21051.
78.Saitou, N., and Nei, M. (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees, Molecular biology and evolution 4, 406-425.
79.Felsenstein, J. (1985) Confidence-Limits on Phylogenies - an Approach Using the Bootstrap, Evolution 39, 783-791.
80.Jones, D. T., Taylor, W. R., and Thornton, J. M. (1992) The rapid generation of mutation data matrices from protein sequences, Computer applications in the biosciences : CABIOS 8, 275-282.
81.Tamura, K., Stecher, G., Peterson, D., Filipski, A., and Kumar, S. (2013) MEGA6: molecular evolutionary genetics analysis version 6.0, Molecular biology and evolution 30, 2725-2729.
82.Sreerama, N., and Woody, R. W. (2000) Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set, Analytical biochemistry 287, 252-260.
83.Sreerama, N., and Woody, R. W. (2004) Computation and analysis of protein circular dichroism spectra, Methods in enzymology 383, 318-351.
84.van Stokkum, I. H., Spoelder, H. J., Bloemendal, M., van Grondelle, R., and Groen, F. C. (1990) Estimation of protein secondary structure and error analysis from circular dichroism spectra, Analytical biochemistry 191, 110-118.
85.Guan, S., Clarke, A. J., and Whitfield, C. (2001) Functional analysis of the galactosyltransferases required for biosynthesis of D-galactan I, a component of the lipopolysaccharide O1 antigen of Klebsiella pneumoniae, Journal of bacteriology 183, 3318-3327.
86.Zamze, S., Martinez-Pomares, L., Jones, H., Taylor, P. R., Stillion, R. J., Gordon, S., and Wong, S. Y. (2002) Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor, The Journal of biological chemistry 277, 41613-41623.
87.Miller, G. L. (1959) Use of dinitrosalicylic acid reagent for determination of reducing sugar, Analytical chemistry 31, 426-428.
88.Danner, M., Fuchs, A., Miller, S., and Seckler, R. (1993) Folding and assembly of phage-P22 tailspike endorhamnosidase lacking the N-terminal, head-binding domain, European Journal of Biochemistry 215, 653-661.
89.Duus, J., Gotfredsen, C. H., and Bock, K. (2000) Carbohydrate structural determination by NMR spectroscopy: modern methods and limitations, Chemical reviews 100, 4589-4614.
90.Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999) Bacterial biofilms: a common cause of persistent infections, Science 284, 1318-1322.
91.Hall-Stoodley, L., Costerton, J. W., and Stoodley, P. (2004) Bacterial biofilms: from the natural environment to infectious diseases, Nature reviews. Microbiology 2, 95-108.
92.Karamoddini, M. K., Fazli-Bazzaz, B. S., Emamipour, F., Ghannad, M. S., Jahanshahi, A. R., Saed, N., and Sahebkar, A. (2011) Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species, The scientific world journal 11, 1332-1340.
93.Vinodkumar, C. S., Neelagund, Y. F., and Kalsurmath, S. (2005) Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae, The Journal of communicable diseases 37, 18-29.
94.Chhibber, S., Kaur, S., and Kumari, S. (2008) Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice, Journal of medical microbiology 57, 1508-1513.
95.Pirisi, A. (2000) Phage therapy--advantages over antibiotics?, Lancet 356, 1418.
96.Lederberg, J. (1996) Smaller fleas ... ad infinitum: therapeutic bacteriophage redux, Proceedings of the national academy of sciences of the United States of America 93, 3167-3168.
97.Avery, O. T., and Dubos, R. (1931) The protective action of a specific enzyme against type III pneumococcus infection in mice, The Journal of experimental medicine 54, 73-89.
98.Gadebusch, H. H. (1960) Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. II. Biological activity of the enzyme, The Journal of infectious diseases 107, 402-405.
99.Mushtaq, N., Redpath, M. B., Luzio, J. P., and Taylor, P. W. (2004) Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype, Antimicrobial agents and chemotherapy 48, 1503-1508.
100.Mushtaq, N., Redpath, M. B., Luzio, J. P., and Taylor, P. W. (2005) Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase, Journal of antimicrobiology and chemotherapy 56, 160-165.
101.Mushtaq, N., Redpath, M. B., Luzio, J. P., and Taylor, P. W. (2004) Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype, Antimicrobial agents and chemotherapy 48, 1503-1508.
102.Scorpio, A., Tobery, S. A., Ribot, W. J., and Friedlander, A. M. (2008) Treatment of experimental anthrax with recombinant capsule depolymerase, Antimicrobial agents and chemotherapy 52, 1014-1020.
103.Berry, D. S., Lynn, F., Lee, C. H., Frasch, C. E., and Bash, M. C. (2002) Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses, Infection and immunity 70, 3707-3713.
104.Daum, R. S., Hogerman, D., Rennels, M. B., Bewley, K., Malinoski, F., Rothstein, E., Reisinger, K., Block, S., Keyserling, H., and Steinhoff, M. (1997) Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines, The Journal of infectious diseases 176, 445-455.
105.Laferriere, C. A., Sood, R. K., de Muys, J. M., Michon, F., and Jennings, H. J. (1998) Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes, Infection and immunity 66, 2441-2446.
106.McCarter, J. D., and Withers, S. G. (1994) Mechanisms of enzymatic glycoside hydrolysis, Current opinion in structural biology 4, 885-892.
107.Collins, T., De Vos, D., Hoyoux, A., Savvides, S. N., Gerday, C., Van Beeumen, J., and Feller, G. (2005) Study of the active site residues of a glycoside hydrolase family 8 xylanase, Journal of molecular biology 354, 425-435.
108.Hermans, M. M., Kroos, M. A., van Beeumen, J., Oostra, B. A., and Reuser, A. J. (1991) Human lysosomal alpha-glucosidase. Characterization of the catalytic site, The Journal of biological chemistry 266, 13507-13512.
109.Thongpoo, P., McKee, L. S., Araujo, A. C., Kongsaeree, P. T., and Brumer, H. (2013) Identification of the acid/base catalyst of a glycoside hydrolase family 3 (GH3) beta-glucosidase from Aspergillus niger ASKU28, Biochimica et biophysica acta 1830, 2739-2749.
110.Yu, H., and Griffiths, T. M. (2014) pKa cycling of the general acid/base in glycoside hydrolase families 33 and 34, Physical chemistry chemical physics : PCCP 16, 5785-5792.
111.Bacik, J. P., Whitworth, G. E., Stubbs, K. A., Vocadlo, D. J., and Mark, B. L. (2012) Active site plasticity within the glycoside hydrolase NagZ underlies a dynamic mechanism of substrate distortion, Chemistry &; biology 19, 1471-1482.
112.Adams, M. H., and Park, B. H. (1956) An enzyme produced by a phage-host cell system. II. The properties of the polysaccharide depolymerase, Virology 2, 719-736.
113.Iwashita, S., and Kanegasaki, S. (1976) Enzymic and molecular properties of base-plate parts of bacteriophage P22, Eur J Biochem 65, 87-94.
114.Liu, Y., Li, G. Y., Mo, Z. L., Chai, Z. H., Shang, A. Q., and Mou, H. J. (2014) Properties of Klebsiella phage P13 and associated exopolysaccharide depolymerase, J of Ocean University of China 13, 163-168.
115.Verma, V., Harjai, K., and Chhibber, S. (2009) Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent, Curr Microbiol 59, 274-281.
116.Kassa, T., and Chhibber, S. (2012) Thermal treatment of the bacteriophage lysate of Klebsiella pneumoniae B5055 as a step for the purification of capsular depolymerase enzyme, Journal of virological methods 179, 135-141.
117.Sutherla.Iw. (1972) Exopolysaccharides of Klebsiella serotype 2 strains as substrates for phage-Induced polysaccharide depolymerases, Journal of general microbiology 70, 331-338.
118.Riegerhug, D., and Stirm, S. (1981) Comparative study of host capsule depolymerases associated with Klebsiella-bacteriophages, Virology 113, 363-378.
119.Geyer, H., Stirm, S., and Himmelspach, K. (1979) Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2 specificity. I. specificity and crossreactivity of anti-conjugate versus anti-bacterial antibodies, Medical microbiology and immunology 165, 271-288.
120.Hsu, C. R., Lin, T. L., Pan, Y. J., Hsieh, P. F., and Wang, J. T. (2013) Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase, PLoS One 8, e70092.
121.Ayling-Smith, B., and Pitt, T. L. (1990) State of the art in typing: Klebsiella spp, The Journal of hospital infection 16, 287-295.
122.Tsay, R. W., Siu, L. K., Fung, C. P., and Chang, F. Y. (2002) Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection, Archives of internal medicine 162, 1021-1027.


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊
 
系統版面圖檔 系統版面圖檔